Celltium
PrivateLast Round
Series A
Dec 13, 2021
Total Funding Raised
$4.64M
Company Overview
Celltium operates in Healthcare & Life Sciences and is based in Suwon. Its latest recorded funding round was a Series A round in December 2021.
Celltium is a biotechnology company that develops precision small-molecule neurotherapeutics for rare neurological diseases such as Charcot-Marie-Tooth disease type 1A.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Celltium Comparables
Compare Celltium with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Standigm | 74% | |
| ToolGen Inc. | 66% | |
| Recursion Pharmaceuticals | 65% |
For institutional investors. Book with your work email.
Celltium Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Celltium Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea University Holdings | Series A |
| SL Investment | Series A |
| Korea Venture Investment Corporation | Series A |
| Daekyo Investment | Series A |
| Shinhan Capital Co., Ltd. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 89% MoM.
- Apr 3, 2026
Monthly visitors grew 33% MoM, reaching 8K.
For institutional investors. Book with your work email.
Celltium Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Celltium's valuation, stock price, and market status.
Is Celltium a public or private company?
Celltium is a private company.
What is the current stock price of Celltium?
Celltium is a private company, so its shares have no public market price. Caplight tracks Celltium's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Celltium worth (valuation)?
Valuation information for Celltium is not publicly available.
Can I buy Celltium stock?
Celltium shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Celltium's last funding round?
Celltium's most recent funding round was Series A on December 13, 2021.
Who are the main investors in Celltium?
Key investors in Celltium include Korea University Holdings, SL Investment, Korea Venture Investment Corporation, Daekyo Investment, Shinhan Capital Co., Ltd..
Will Celltium IPO soon?
No public IPO plans have been announced for Celltium.
How can I track Celltium secondary market activity?
Caplight tracks bids, offers, and trades in Celltium's shares on secondary markets.